R Zacest, J Koch-Weser. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AcylationAdministration, OralAdultBlood Pressure/drug effectsFemaleHumansHydralazine/administration & dosageHydralazine/bloodHydralazine/therapeutic useHypertension/bloodHypertension/drug therapyMaleMiddle AgedPhenotypePropranolol/pharmacologySulfamethazine/urineTime Factors
Substances: See more » HydralazineSulfamethazinePropranolol
Year: 1972 PMID: 5026380 DOI: 10.1002/cpt1972133420
Source DB: PubMed Journal: Clin Pharmacol Ther ISSN: 0009-9236 Impact factor: 6.875